ATP is a leading life sciences fund with global presence and reach that is developing the next generation of transformative biotechnology companies.

ATP brings together over $2.5 billion under management, one of the sector’s most highly selective funding methodologies, and a seasoned team of venture partners to create a proven hub-and-spoke model.

ATP works with the world’s most innovative life scientists and provides the capital, expertise, and operational intelligence to build new companies and drive long-term value.